Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Latest filing published 21 Nov 2017 for Valeant Pharmaceuticals International, Inc., €106k. Read the official filing
Filing timeline
BuySaleJohn Paulson
Insider track record
Disclosed buys
2
Disclosed sells
2
Signal history
No signal scores available.
John Paulson: trading record in brief
All filings by John Paulson on record concern Valeant Pharmaceuticals International, Inc. In total, 16 filings cover trades dated from 14 June 2017 to 16 November 2017.
The open-market side counts 2 purchases for €3.3M alongside 2 sales for €3.3M. Purchases outweigh sales by €1,787. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 21 November 2017 with an open-market sale (€106k) in Valeant Pharmaceuticals International, Inc. The latest purchase dates back some time: it was published 3,256 days ago, on 21 November 2017. The median gap between a trade and its publication by SEDI is 12 days. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Companies and markets linked to John Paulson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
11,103 shares@ CA$14.3887Common SharesTSXSEDI:3086154
333,113 shares@ CA$14.3887Common SharesTSXSEDI:3086153
98,256 shares@ CA$14.3965Common SharesTSXSEDI:3086150
Canonical exit: 14 Feb 2018 (T+90)
245,960 shares@ CA$14.3965Common SharesTSXSEDI:3086152
Canonical exit: 14 Feb 2018 (T+90)
Common SharesTSXSEDI:3026332
Common SharesTSXSEDI:3026335
Common SharesTSXSEDI:3026336
Common SharesTSXSEDI:3026334
Common SharesTSXSEDI:3026337
Common SharesTSXSEDI:3026333
Common SharesTSXSEDI:3026340
Common SharesTSXSEDI:3026339
Common SharesTSXSEDI:3026312
Common SharesTSXSEDI:3026313
Common SharesTSXSEDI:3026314
Common SharesTSXSEDI:3026317
16 of 16 declarations
